| Gene symbol | IL12A | Synonyms | CLMF, IL-12A, NFSK, NKSF1, P35 | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3q25.33 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | interleukin 12A | ||||
| Gene symbol | IL12B | Synonyms | CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF, NKSF2 | Type of gene | protein-coding |
| Chromosome | 5 | Map location | 5q33.3 | dbXrefs | |
| Description | interleukin 12B | ||||
| GTO ID | GTC0143 |
| Trial ID | NCT01579318 |
| Disease | Primary Cutaneous T-Cell Non-Hodgkin's Lymphoma |
| Altered gene | IL-12A|IL-12B |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | pIL-12 |
| Phase | Phase2 |
| Recruitment status | Terminated |
| Title | A Multicenter Phase II Trial of Intratumoral IL12 Plasmid Electroporation in Cutaneous Lymphoma |
| Year | 2012 |
| Country | United States |
| Company sponsor | OncoSec Medical Incorporated |
| Other ID(s) | OMS-I120 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||||
|
|||||||||||||